Table 1.
Baseline demographics and history of treatment (N = 101).
| Type | Variables | Mean (Min, Max) or Count (%) |
|---|---|---|
| Demographics | Age, Years | 30.11 (18.00–50.00) |
| Gender | ||
| Male | 65 (64.36%) | |
| Female | 36 (35.64%) | |
| Occupation | ||
| Yes | 72 (71.29%) | |
| Marriage | ||
| Yes | 22 (21.78%) | |
| Disease Onset | ||
| Adult exacerbation | 13 (12.87%) | |
| Childhood | 88 (87.13%) | |
| Family History of Allergy | ||
| Yes | 35 (34.65%) | |
| Allergy History | 77 (76.24%) | |
| Allergic conjunctivitis | 14 (18.18%) | |
| Allergic rhinitis | 52 (67.53%) | |
| Asthma | 11 (14.29%) | |
| Known Allergy | 75 (74.26%) | |
| House dust mite | 43 (57.33%) | |
| Mold | 17 (22.67%) | |
| Food | 8 (10.67%) | |
| Cat | 4 (5.33%) | |
| Dog | 3 (4.00%) | |
| Ocular Disease Telated to Past Treatment | 18 (17.82%) | |
| Cataract | 6 (33.33%) | |
| Cataract (had operation) | 7 (38.89%) | |
| Corneal transplantation | 1 (5.56%) | |
| Glaucoma | 2 (11.10%) | |
| Retinal detachment | 2 (11.10%) | |
| History of treatment | Topical Treatment | |
| Topical steroid | 89 (88.12%) | |
| Topical calcineurin inhibitor | 66 (65.35%) | |
| Systemic Treatment | ||
| Systemic steroid | 66 (65.35%) | |
| Immunosuppressant | 73 (72.28%) | |
| Cyclosporine | 61 (82.43%) | |
| Methotrexate | 9 (12.16%) | |
| Mycophenolate mofetil | 2 (2.70%) | |
| Azathioprine | 1 (1.35%) | |
| Phototherapy | 10 (9.90%) | |
| Oriental medicine | 43 (42.57%) | |
| Folk remedy | 6 (5.94%) |